The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma. (2021)
Attributed to:
Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.20517/jtgg.2021.27
PubMed Identifier: 34888493
Publication URI: http://europepmc.org/abstract/MED/34888493
Type: Journal Article/Review
Volume: 5
Parent Publication: Journal of translational genetics and genomics
ISSN: 2578-5281